A clinical and genetic study of 33 new cases with early-onset absence epilepsy

Epilepsy Res. 2011 Aug;95(3):221-6. doi: 10.1016/j.eplepsyres.2011.03.017. Epub 2011 May 4.

Abstract

Purpose: To investigate the electroclinical features and the outcome of patients with typical absences starting before the 3 years of life.

Methods: We reviewed the clinical data of patients with absences started before 3 years observed over a 15-year period. Mutation analysis of SLC2A1 (GLUT-1) gene was performed when possible. Their clinical features were compared with those of subjects with a diagnosis of childhood absence epilepsy (CAE).

Results: Among 33 children with absence epilepsy starting before 3 years of life, there were 20 boys and 13 girls. Mean seizure onset was at 28.0 ± 8.3 (range: 8-36) months of life. Two children displayed borderline intellectual functioning at long-term follow-up. Twenty-eight (85%) patients showed excellent response to therapy. Three subjects evolved into a different form of idiopathic generalized epilepsy (IGE). No SLC2A1 mutation was identified in 20 (60.6%) patients tested. The main clinical features of patients with early-onset absences did not differ from those of CAE except for increased prevalence of males (p=0.002) and longer treatment duration (p=0.001) in the former.

Conclusions: Strong similarities in the electroclinical features and outcome between children with early-onset absences and those with CAE support the view that these conditions are part of the wide spectrum of IGE.

Publication types

  • Multicenter Study

MeSH terms

  • Age of Onset
  • Child, Preschool
  • DNA Mutational Analysis
  • Electroencephalography
  • Epilepsy, Absence / genetics*
  • Female
  • Glucose Transporter Type 1 / genetics*
  • Humans
  • Infant
  • Italy
  • Male
  • Mutation / genetics*
  • Retrospective Studies

Substances

  • Glucose Transporter Type 1
  • SLC2A1 protein, human